New FDA Drug Approved to Help Premenopausal Women with Hypoactive Sexual Desire Disorder.
Vyleesi was recently approved by the FDA for premenopausal women who have low libido.
How is it given?
Given subcutaneously 45 minutes before intercourse
What are the results?
Women exhibit marked increase in sexual desire and consequently a very satisfying sexual interaction.
Who benefits from this treatment?
It benefits premenopausal women with
Hypoactive Sexual Desire Disorder(HSDD)
Who does not benefit from Vyeelesi Treatment?
For anyone trying to enhance sexual performance
Any side effects?
1. Transient increase in blood pressure
Transient lowering of heart rate
Nausea and or vomiting
Injection site reaction
Vyeelesi can help young women who do not have any medical or psychological issues affecting their sexual life including relationship issues or due to taking medications or drugs.
If you want to learn more or need help please call us at (703) 992-9815 or send us an email @ email@example.com
Dr. Anteneh Roba